Alignment Healthcare Beats Expectations with Strong Second-Quarter Revenue Growth

2026-07-31 companies

Orange, Thursday, 30 July 2026.
Driven by a 31.5% jump in Medicare Advantage enrollment, Alignment Healthcare generated $1.34 billion in second-quarter 2026 revenue, beating financial estimates and raising its full-year outlook.

Revenue Surge and Membership Expansion

Alignment Healthcare (NASDAQ: ALHC) reported second-quarter 2026 financial results on July 30, 2026, delivering total revenue of $1,335.63 million [1]. This figure represents a significant year-over-year increase from the $1,015.29 million recorded in the same period of 2025, translating to a growth rate of 31.552 percent [1]. The company’s Medicare Advantage membership also saw substantial expansion, rising 31.5% year-over-year to approximately 294,100 members as of June 30, 2026 [1]. This enrollment growth outpaces some peer performance, contrasting with broader market expectations that had projected a 29% year-over-year revenue growth for the quarter [4]. The robust top-line expansion signals sustained operational momentum within the competitive value-based care sector, highlighting stronger market adoption despite previous analyst concerns regarding deceleration [4].

Profitability Metrics and Forward Guidance

Beyond top-line revenue, Alignment Healthcare demonstrated improved profitability metrics, reporting an adjusted gross profit of $182.9 million, which is up 35.3% year-over-year [1]. Adjusted EBITDA for the quarter reached $68.1 million, marking a 48.4% increase from the previous year, while net income rose to $36.6 million from $15.7 million in the second quarter of 2025 [1]. Following these results, the company raised the midpoint of its full-year 2026 guidance across key metrics, including membership, revenue, and adjusted EBITDA [1]. For the twelve months ending December 31, 2026, the company projects membership between 298,000 and 301,000, with total revenue expected between $5,195 million and $5,225 million [1]. These projections suggest confidence in the company’s ability to maintain its growth trajectory throughout the remainder of the fiscal year.

Market Reaction and Legal Context

Investor sentiment surrounding Alignment Healthcare has been influenced by both financial performance and recent legal developments. On July 30, 2026, shares traded between a low of $17.00 and a high of $19.10, closing at $18.49 [5]. This trading activity follows a period of volatility, including a decline in late July 2026 after law firm Kaplan Fox & Kilsheimer LLP announced an investigation into potential securities violations on July 28, 2026 [3][6]. The investigation stems from a whistleblower complaint filed on July 8, 2026, alleging accounting irregularities involving the classification of operating expenses [6]. While the company maintains that such allegations are meritless, the situation remains a factor for investors monitoring governance risks alongside financial growth [3][6]. Analysts currently maintain an average price target of $24.83, implying potential upside despite the recent turbulence [2].

Sources

Medicare Advantage Alignment Healthcare